The Trump team lied. Project 2025 is influential with his transition team and his second cabinet.
Project 2025 Could Impact the Economy and Your Finances
What economic proposals are in Project 2025?
Most of Project 2025 would have economic implications if implemented and many proposals would affect Americans on a personal finance level. While this is not an exhaustive list, here are some key proposals:
Read More »
FDA Settles Lawsuit over Ivermectin Social Media Posts
The FDA has agreed to delete and never republish several social-media posts suggesting that ivermectin, a drug that some doctors used to treat COVID-19, is for animals and not humans.
While the FDA still does not approve of using ivermectin to treat COVID, it settled Thursday a lawsuit brought by three doctors who sued it, as well as the Department of Health and Human Services and its secretary, Xavier Becerra, and FDA secretary Robert Califf. All parties have settled.
…
At its website as of Friday, the FDA still is not recommending it for COVID and says large doses are dangerous and that prescriptions should be filled by a pharmacy and taken exactly as prescribed.
The FDA declined to respond to Kennedy’s assertion, though it reiterated that it “has not changed its position that currently available clinical trial data do not demonstrate that ivermectin is effective against COVID-19. The agency has not authorized or approved ivermectin for use in preventing or treating COVID-19.”
I honestly don’t know what difference this’ll make. 🤷🏼♀️
A coalition of religious anti-abortion organizations has filed a lawsuit in Amarillo, Texas, aimed at overturning FDA approval for mifepristone, a medication used in medical abortions. The lawsuit is unprecedented, with no previous cases having sought to overturn FDA approval for a drug.
Anti-abortion zealots, federal judge conspire to ban abortion pill mifepristone
Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of investigational medicines before they hit the market. But do they have sufficient independence from the companies they are meant to regulate? Maryanne Demasi investigates
From FDA to MHRA: are drug regulators for hire?
Ms. Cat’s Chronicles 